CME Group (CME) Stock Price, News & Analysis

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last twelve months. There are currently 2 sell ratings, 6 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CME shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CME, but not buy additional shares or sell existing shares.
View CME analyst ratings or view top-rated stocks.

10 equities research analysts have issued 12 month price objectives for CME Group's shares. Their CME share price targets range from $180.00 to $245.00. On average, they expect the company's share price to reach $215.70 in the next twelve months. This suggests a possible upside of 4.5% from the stock's current price.
View analysts price targets for CME or view top-rated stocks among Wall Street analysts.

CME Group's stock was trading at $210.60 at the beginning of the year. Since then, CME stock has decreased by 2.0% and is now trading at $206.48.
View the best growth stocks for 2024 here.

CME Group saw a increase in short interest in March. As of March 31st, there was short interest totaling 4,420,000 shares, an increase of 18.2% from the March 15th total of 3,740,000 shares. Based on an average trading volume of 1,750,000 shares, the short-interest ratio is presently 2.5 days. Currently, 1.2% of the company's stock are short sold.
View CME Group's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 24th 2024.
View our CME earnings forecast.

CME Group will be holding an earnings conference call on Wednesday, April 24th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

CME Group Inc. (NASDAQ:CME) issued its quarterly earnings data on Wednesday, February, 14th. The financial services provider reported $2.37 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.27 by $0.10. The financial services provider earned $1.44 billion during the quarter, compared to analysts' expectations of $1.43 billion. CME Group had a trailing twelve-month return on equity of 12.32% and a net margin of 57.83%. The firm's revenue was up 19.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.92 EPS.
Read the conference call transcript.

CME Group declared a quarterly dividend on Thursday, February 8th. Stockholders of record on Friday, March 8th will be paid a dividend of $1.15 per share on Tuesday, March 26th. This represents a $4.60 annualized dividend and a yield of 2.23%. The ex-dividend date of this dividend is Thursday, March 7th. This is an increase from the stock's previous quarterly dividend of $1.10.
Read our dividend analysis for CME.

CME Group (NASDAQ:CME) pays an annual dividend of $4.60 per share and currently has a dividend yield of 2.20%. The company has been increasing its dividend for 14 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 51.86%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CME will have a dividend payout ratio of 47.62% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CME.

ETFs with the largest weight of CME Group (NASDAQ:CME) stock in their portfolio include Horizon Kinetics Blockchain Development ETF (BCDF), iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI), Amplify YieldShares CWP Dividend & Option Income ETF (DIVO), Tema Monopolies and Oligopolies ETF (TOLL), SmartETFs Dividend Builder ETF (DIVS), Capital Link Global Fintech Leaders ETF (KOIN), TrueShares Low Volatility Equity Income ETF (DIVZ) and USCF Dividend Income Fund (UDI).

294 employees have rated CME Group Chief Executive Officer Terry Duffy on Glassdoor.com. Terry Duffy has an approval rating of 83% among the company's employees. 80.0% of employees surveyed would recommend working at CME Group to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other CME Group investors own include NVIDIA (NVDA), Mastercard (MA), PayPal (PYPL), Walt Disney (DIS), Visa (V), Netflix (NFLX), Boeing (BA), Alibaba Group (BABA), Cisco Systems (CSCO) and Intel (INTC).

CME Group's stock is owned by a variety of institutional and retail investors. Top institutional investors include Sarasin & Partners LLP (0.63%), Guinness Asset Management LTD (0.24%), Congress Asset Management Co. MA (0.11%), Los Angeles Capital Management LLC (0.07%), Franklin Street Advisors Inc. NC (0.05%) and Global Assets Advisory LLC (0.04%). Insiders that own company stock include Bryan T Durkin, Charles P Carey, Daniel R Glickman, Dennis Suskind, Derek Sammann, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Ken Vroman, Kevin Kometer, Martin J Gepsman, Martin J Gepsman, Sean Tully, Sunil Cutinho, Terrence A Duffy, Timothy Francis Mccourt, Timothy S Bitsberger and William R Shepard.
View institutional ownership trends.

Shares of CME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.